Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.
Doz, F
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study. [electronic resource] - British journal of cancer Mar 2001 - 604-10 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
0007-0920
10.1054/bjoc.2000.1637 doi
Adolescent
Adult
Antineoplastic Agents, Phytogenic--administration & dosage
Child
Child, Preschool
Drug Hypersensitivity--etiology
Ethanol--pharmacokinetics
Female
Humans
Infant
Infusions, Intravenous
Male
Maximum Tolerated Dose
Neoplasm, Residual--drug therapy
Neurotoxicity Syndromes--etiology
Paclitaxel--administration & dosage
Polyethylene Glycols--pharmacokinetics
Solvents--pharmacokinetics
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study. [electronic resource] - British journal of cancer Mar 2001 - 604-10 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
0007-0920
10.1054/bjoc.2000.1637 doi
Adolescent
Adult
Antineoplastic Agents, Phytogenic--administration & dosage
Child
Child, Preschool
Drug Hypersensitivity--etiology
Ethanol--pharmacokinetics
Female
Humans
Infant
Infusions, Intravenous
Male
Maximum Tolerated Dose
Neoplasm, Residual--drug therapy
Neurotoxicity Syndromes--etiology
Paclitaxel--administration & dosage
Polyethylene Glycols--pharmacokinetics
Solvents--pharmacokinetics